Primer, probe, kit and method for detection of human ALDH2 gene polymorphism
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI TISSUEBANK MEDICAL LAB CO LTD
- Publication Date
- 2017-07-14
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of genetic engineering, in particular to primers, probes, kits and methods for detecting human ALDH2 gene polymorphisms. Background technique
[0002] Nitroglycerin is an emergency drug for the prevention and treatment of coronary heart disease and angina. The enzyme promotes calcium ions to enter the sarcoplasmic reticulum and the extracellular space, thereby dilating vascular smooth muscle and relieving the symptoms of cardiac ischemia. The polymorphism of ALDH2*2 (Glu504Lys, rs671) leads to the substitution of glutamic acid at position 504 of the encoded protein by lysine, and the ALDH2 enzyme activity of individuals carrying the mutant allele ALDH2*2 decreases, and the enzyme activity of heterozygotes is only wild type In 10% of individuals, the mutation is homozygous for loss of enzyme activity. Therefore, patients with ALDH2*2 type cannot use nitroglycerin to resist myocardial ischemia. The carrier ...